MRP: 1,050.00

PTR: ₹750 | PTS: ₹675

Composition: Each Kit contains Fluconazole 150 mg , .
1Tab. Azithromycin 1gm , 2 Tab.Secnidazole 1gm

Packing : 1*4 blister

SKU: ffbb050407fa Category:

Description

This combination therapy kit is designed to effectively treat mixed infections, particularly those caused by bacterial and fungal pathogens. The combination of Fluconazole, Azithromycin, and Secnidazole provides a comprehensive approach to managing sexually transmitted infections (STIs), vaginal infections, and mixed bacterial-fungal infections.

Composition & Mechanism of Action:

  • Fluconazole 150 mg: An antifungal agent that works by inhibiting the synthesis of fungal cell membranes, effectively treating fungal infections.
  • Azithromycin 1 gm: A broad-spectrum macrolide antibiotic that prevents bacterial protein synthesis, treating a variety of bacterial infections.
  • Secnidazole 1 gm (2 Tablets): An anti-protozoal and antibacterial agent effective against anaerobic bacteria and certain protozoa.

Key Benefits:

✔ Comprehensive treatment for mixed bacterial, fungal, and protozoal infections
✔ Effectively manages vaginal infections, STIs, and bacterial vaginosis
✔ Convenient single-dose therapy, improving patient compliance
✔ Reduces the recurrence of infections with its broad-spectrum activity

Indications:

  • Mixed bacterial and fungal infections
  • Vaginal infections like bacterial vaginosis and vulvovaginal candidiasis
  • Sexually transmitted infections (STIs)
  • Trichomoniasis and other protozoal infections

Dosage & Administration:

  • Fluconazole: 150 mg – Single dose
  • Azithromycin: 1 gm – Single dose
  • Secnidazole: 1 gm (2 tablets) – Single dose
  • Administer as directed by a healthcare professional.

Side Effects:

  • Nausea, vomiting, and diarrhea
  • Abdominal discomfort
  • Headache and dizziness
  • Allergic reactions like rash or itching (rare)
  • Metallic taste (due to Secnidazole)

Important Notice

This is temp data

Use only as directed by a qualified healthcare professional.